Funds holding ADIAL PHARMACEUTICALS INC
ISIN US00688A3041 · United States
- Fund holders
- 3
- Of which ETFs
- 0 3 other funds
- Value held
- 58.3K $
- Share of capital
- 0.9 % of 2.6M shares on Aug 12, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 23,596 | 56.6K $ | 0.00 % | 0.90 % | as of May 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 361 | 924.2 $ | 0.01 % | as of Jun 30, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 310 | 744 $ | 0.01 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 3 | -1 | 24,267 | +284.3 % |
| 2026Q2 | 4 | 6,314 |
Institutional managers
12 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 24,249 | 43.4K $ | as of Mar 31, 2026 |
| Manchester Capital Management LLC | 1,923 | 3.4K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 1,356 | 2.4K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 1,110 | 2K $ | as of Mar 31, 2026 |
| UBS Group AG | 542 | 970 $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 50 | 90 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 47 | 84 $ | as of Mar 31, 2026 |
| Caitong International Asset Management Co., Ltd | 15 | 27 $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 6 | 11 $ | as of Mar 31, 2026 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 4 | 7 $ | as of Mar 31, 2026 |
| HARBOUR INVESTMENTS, INC. | 3 | 5 $ | as of Mar 31, 2026 |
| Abound Wealth Management | 1 | 2 $ | as of Mar 31, 2026 |
Declared shareholders of ADIAL PHARMACEUTICALS INC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Coastlands Capital LP and 4 others | 14.22 % | 373,322 | as of Jun 24, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding ADIAL PHARMACEUTICALS INC". https://titelia.com/en/stocks/adial-pharmaceuticals-inc-US00688A3041